risedronic acid has been researched along with Alloxan Diabetes in 1 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bentinger, M | 1 |
| Kania, M | 1 |
| Danikiewicz, W | 1 |
| Kaczorowska, E | 1 |
| Wojcik, J | 1 |
| Brismar, K | 1 |
| Dallner, G | 1 |
| Chojnacki, T | 1 |
| Swiezewska, E | 1 |
| Tekle, M | 1 |
1 other study available for risedronic acid and Alloxan Diabetes
| Article | Year |
|---|---|
Effects of various squalene epoxides on coenzyme Q and cholesterol synthesis.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Cholesterol; Diabetes Mellitus, Experimental; Etid | 2014 |